Mirvetuximab Soravtansine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB12489 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | antithrombin deficiency type 2 | KG + DL |
| 2 | heparin cofactor 2 deficiency | KG + DL |
| 3 | factor 5 excess with spontaneous thrombosis | KG + DL |
| 4 | candidiasis | KG + DL |
| 5 | plasma cell myeloma | KG + DL |
| 6 | indolent plasma cell myeloma | KG + DL |
| 7 | tinea corporis | KG + DL |
| 8 | thrombophilia | KG + DL |
| 9 | uterine polyp | KG + DL |
| 10 | pediatric systemic lupus erythematosus | KG + DL |
| 11 | polyp of vocal cord | KG + DL |
| 12 | polyp of middle ear | KG + DL |
| 13 | polyp of frontal sinus | KG + DL |
| 14 | polyp of external auditory canal | KG + DL |
| 15 | polyp of ureter | KG + DL |
| 16 | polyp of vulva | KG + DL |
| 17 | fibroepithelial polyp | KG + DL |
| 18 | neoplastic polyp | KG + DL |
| 19 | epulis | KG + DL |
| 20 | mantle cell lymphoma | KG + DL |
| 21 | acne (disease) | KG + DL |
| 22 | HER2 positive breast carcinoma | KG + DL |
| 23 | primary release disorder of platelets | KG + DL |
| 24 | primary cutaneous T-cell lymphoma | KG + DL |
| 25 | lymphosarcoma | KG + DL |
| 26 | pseudo-von Willebrand disease | KG + DL |
| 27 | nasal cavity polyp | KG + DL |
| 28 | Glanzmann thrombasthenia | KG + DL |
| 29 | bronchitis | KG + DL |
| 30 | lymph node cancer | KG + DL |
| 31 | conjunctivitis | KG + DL |
| 32 | oral candidiasis | KG + DL |
| 33 | Bacteroidaceae infectious disease | KG + DL |
| 34 | complement component 4a deficiency | KG + DL |
| 35 | normal breast-like subtype of breast carcinoma | KG + DL |
| 36 | progesterone-receptor positive breast cancer | KG + DL |
| 37 | autoimmune hemolytic anemia | KG + DL |
| 38 | progesterone-receptor negative breast cancer | KG + DL |
| 39 | breast tumor luminal A or B | KG + DL |
| 40 | leprosy | KG + DL |
| 41 | atopic eczema | KG + DL |
| 42 | scalp dermatosis | KG + DL |
| 43 | conjunctivitis (disease) | KG + DL |
| 44 | heart disease | KG + DL |
| 45 | migraine disorder | KG + DL |
| 46 | migraine with brainstem aura | KG + DL |
| 47 | anaerobic bacteria infectious disease | KG + DL |
| 48 | commissural lip fistula | KG + DL |
| 49 | primary cutaneous B-cell lymphoma | KG + DL |
| 50 | oral leukoedema | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.